Cargando…
Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.
Residual retroperitoneal masses may remain after chemotherapy for metastatic non-seminomatous testicular cancer, which harbour residual tumour or totally benign tissue (necrosis/fibrosis). These residual masses may be effectively removed by a surgical resection. We evaluated current selection criter...
Autores principales: | Steyerberg, E. W., Keizer, H. J., Fosså, S. D., Sleijfer, D. T., Bajorin, D. F., Donohue, J. P., Habbema, J. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074767/ https://www.ncbi.nlm.nih.gov/pubmed/8912551 |
Ejemplares similares
-
External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients
por: Vergouwe, Y, et al.
Publicado: (2003) -
Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.
por: Steyerberg, E. W., et al.
Publicado: (1993) -
Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
por: Jacobsen, K D, et al.
Publicado: (1999) -
Fertility in Norwegian testicular cancer patients
por: Fosså, S D, et al.
Publicado: (2000) -
RE: The value of testicular ultrasound in the prediction of the type and size of testicular tumors
por: Shtricker, Abraham, et al.
Publicado: (2016)